Related references
Note: Only part of the references are listed.European Pharmacopoeia Activities on Control of Nitrosamines and other DNA-Reactive Impurities
Ulrich Rose
JOURNAL OF PHARMACEUTICAL SCIENCES (2023)
Development and Validation of a Novel LC-MS/MS Method for the Simultaneous Determination of Abemaciclib, Palbociclib, Ribociclib, Anastrozole, Letrozole, and Fulvestrant in Plasma Samples: A Prerequisite for Personalized Breast Cancer Treatment
Lu Turkovic et al.
PHARMACEUTICALS (2022)
Inhibiting CDK4/6 in Breast Cancer with Palbociclib, Ribociclib, and Abemaciclib: Similarities and Differences
C. Louwrens Braal et al.
DRUGS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Establishment of an analytical method for simultaneous quantitation of CDK4/6 inhibitors, aromatase inhibitors, and an estrogen receptor antagonist in human plasma using LC-ESI-MS/MS
Yu Sato et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2021)
Can we replace liquid chromatography with the greener capillary electrophoresis?
Muhandiramge Ranasinghe et al.
CURRENT OPINION IN GREEN AND SUSTAINABLE CHEMISTRY (2021)
Green, Cost-Effective Simultaneous Assay of Chloramphenicol, Methylparaben, and Propylparaben in Eye-Drops by Capillary Zone Electrophoresis
Thi Thanh Vuong Tong et al.
JOURNAL OF ANALYTICAL METHODS IN CHEMISTRY (2021)
Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Metastatic Breast Cancer in Young Women: Emerging Data in the Era of Molecularly Targeted Agents
Ami N. Shah et al.
ONCOLOGIST (2020)
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE)
Stephen R. D. Johnston et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Development and validation of a bioanalytical method for the quantification of the CDK4/6 inhibitors abemaciclib, palbociclib, and ribociclib in human and mouse matrices using liquid chromatography-tandem mass spectrometry
Alejandra Martinez-Chavez et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2019)
Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer
S. -A. Im et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Application of the Principles of Green Chemistry for the Development of a New and Sensitive Method for Analysis of Ertapenem Sodium by Capillary Electrophoresis
Tahisa Marcela Pedroso et al.
INTERNATIONAL JOURNAL OF ANALYTICAL CHEMISTRY (2019)
Optimization and validation of RP-HPLC method for simultaneous estimation of palbociclib and letrozole
Yuvraj Dange et al.
TOXICOLOGY MECHANISMS AND METHODS (2018)
Optimization and validation of RP-HPLC method for simultaneous estimation of palbociclib and letrozole
Yuvraj Dange et al.
TOXICOLOGY MECHANISMS AND METHODS (2018)
A new tool for the evaluation of the analytical procedure: Green Analytical Procedure Index
J. Plotka-Wasylka
TALANTA (2018)
Palbociclib and Letrozole in Advanced Breast Cancer
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
A green capillary zone electrophoresis method for the simultaneous determination of piperacillin, tazobactam and cefepime in pharmaceutical formulations and human plasma
Amirah Al-Attas et al.
BIOMEDICAL CHROMATOGRAPHY (2015)
Recent advances in capillary electrophoretic migration techniques for pharmaceutical analysis
Sami El Deeb et al.
ELECTROPHORESIS (2014)
Analytical Eco-Scale for assessing the greenness of analytical procedures
Agnieszka Galuszka et al.
TRAC-TRENDS IN ANALYTICAL CHEMISTRY (2012)
Green analytical methodologies
Lawrence H. Keith et al.
CHEMICAL REVIEWS (2007)
Capillary electrophoresis for the analysis of small-molecule pharmaceuticals
Kevin Altria et al.
ELECTROPHORESIS (2006)